Constellate Proteomics raises an undisclosed amount pre seed
Announced 20 October 2026
◆ The Round
Constellate Proteomics raised an undisclosed amount in pre seed funding, announced on 20 October 2026, led by Graduate Ventures, with participation from Tech Scout Venture Fund, imec.istart. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.
◆ About Constellate Proteomics
A Delft-based deeptech company that builds single-molecule tools to help biopharma teams judge the quality of antibody-producing cell lines earlier in development. Constellate Proteomics is based in Netherlands and currently at pre seed stage, operating in Biotech.
◆ Investors
LeadGraduate Ventures
ParticipationTech Scout Venture Fund, imec.istart
◆ Investing funds on Raise
◆ Market context
Graduate Ventures is profiled on Raise, Fusion42's database of venture funds — where each investor's thesis, cheque size and other tracked backings can be followed. This funding event is a citable node in Fusion42's market graph: it links Constellate Proteomics's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.
◆ Explore the market
◆ FAQ
How much did Constellate Proteomics raise?
Constellate Proteomics raised an undisclosed amount in its pre-seed round, announced 2026-10-20.
Who invested in Constellate Proteomics's pre-seed round?
The round was led by Graduate Ventures, with participation from Tech Scout Venture Fund and imec.istart.
What does Constellate Proteomics do?
A Delft-based deeptech company that builds single-molecule tools to help biopharma teams judge the quality of antibody-producing cell lines earlier in development.
Verified 20 October 2026 · Sources: public filings